Original paper
Subacute Doxorubicin-Induced Cardiomyopathy with Reduced Ejection Fraction and Optimal Recovery of Left Ventricular Ejection Fraction After Medical Heart Failure Treatment
Abstract
Background: Doxorubicin, an anthracycline compound commonly used as a chemotherapeutic agent is well known to cause cardiotoxicity. It is generally regarded that once cardiotoxicity occurs, the damage done would be irreversible. Early-onset cardiomyopathy induced by doxorubicin often occurs during the 1st year after the completion of chemotherapy. Medical therapy use has been by large uncertain in its efficacy, but not all hope is lost. We...
Paper Details
Title
Subacute Doxorubicin-Induced Cardiomyopathy with Reduced Ejection Fraction and Optimal Recovery of Left Ventricular Ejection Fraction After Medical Heart Failure Treatment
Published Date
Dec 1, 2018
Volume
273
Pages
6 - 6
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History